Copyright
©The Author(s) 2022.
World J Gastroenterol. Dec 7, 2022; 28(45): 6380-6396
Published online Dec 7, 2022. doi: 10.3748/wjg.v28.i45.6380
Published online Dec 7, 2022. doi: 10.3748/wjg.v28.i45.6380
Table 2 Genotype 1b-infected patients with liver cirrhosis treated with direct-acting antivirals
| Parameter | GT1b patients, n = 2768 |
| History of hepatic decompensation, n (%) | |
| Ascites | 322 (11.6) |
| Encephalopathy | 87 (3.1) |
| Documented esophageal varices, n (%) | 860 (31) |
| Hepatic decompensation at baseline, n (%) | |
| Ascites - moderate responded to diuretics and tense | 164 (5.9) |
| Encephalopathy | 72 (0.3) |
| Child-Pugh, n (%) | |
| B | 362 (13.1) |
| C | 20 (0.1) |
| No data | 223 (8.1) |
- Citation: Zarębska-Michaluk D, Brzdęk M, Jaroszewicz J, Tudrujek-Zdunek M, Lorenc B, Klapaczyński J, Mazur W, Kazek A, Sitko M, Berak H, Janocha-Litwin J, Dybowska D, Supronowicz Ł, Krygier R, Citko J, Piekarska A, Flisiak R. Best therapy for the easiest to treat hepatitis C virus genotype 1b-infected patients. World J Gastroenterol 2022; 28(45): 6380-6396
- URL: https://www.wjgnet.com/1007-9327/full/v28/i45/6380.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i45.6380